CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products - Celia N. Cruz; Katherine M. Tyner; Lydia Velazquez; Kenneth C. Hyams; Abigail Jacobs; Arthur B. Shaw; Wenlei Jiang; Robert Lionberger; Peter Hinderling; Yoon Kong; Paul C. Brown; Tapash Ghosh; et al. (The AAPS Journal, 2013)

CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells - Qiming Chen; Carol D. Manning; Hillary Millar; Francis L. McCabe; Catherine Ferrante; Celia Sharp; Lillian Shahied-Arruda; Parul Doshi; Marian T. Nakada; G. Mark Anderson (Clinical & Experimental Metastasis, 2008)